EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Epithelial YPEL3 Modulates CD8 + T‐Cell Infiltration and Tumor Progression Through CREB1–CXCL16 Signaling in HNSCC

Yalun Li, Yumei Li, Caiyu Sun, Congxian Lu, Gang Chen iD, Tianshu Zhou, Bei Zhang, Xicheng Song iD

Cancer Science · 2026-08 · 117 (8) · 2132-2151

DOI: 10.1111/cas.70409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 25.05.2026. Verfasst von Yalun Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Squamous Cell Carcinoma of Head and Neck, Chemokine CXCL16, Cyclic AMP Response Element-Binding Protein. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Yippee‐like 3 (YPEL3) has been implicated in the regulation of apoptosis, proliferation, and invasion in various cancers, but its role in head and neck squamous cell carcinoma (HNSCC) remains unclear. Here, we integrated pan‐cancer data, TCGA/GEO transcriptomes, DNA methylation profiles, and single‐cell RNA sequencing to explore YPEL3's expression, prognosis, and immune relevance in HNSCC. YPEL3 was downregulated in tumor tissues and correlated with better overall survival, particularly in advanced‐stage patients. Functional assays confirmed that YPEL3 suppressed proliferation, migration, and invasion while promoting apoptosis in vitro; its knockdown accelerated tumor growth in vivo. Bulk transcriptomics and TIMER analysis revealed that high YPEL3 expression was associated with increased stromal and immune infiltration, including CD8 + T cells. Single‐cell analysis identified an epithelial subcluster (Epi.C3) enriched for YPEL3, expanded in tumors, and linked to poor prognosis. Mechanistically, YPEL3‐high epithelial cells secreted CXCL16, interacting with CXCR6 on CD8 + T cells to promote immune engagement. YPEL3 regulated CXCL16 via CREB1 but not TFAP2C. Co‐culture assays showed that epithelial YPEL3 modulated the CXCL16–CXCR6 axis in T cells. In vivo, YPEL3 loss was associated with reduced CD8 + T‐cell infiltration and impaired CD8 + T‐cell effector function, as indicated by decreased Granzyme B, Perforin, IFN‐γ, and TNF‐α. Together, these findings identify YPEL3 as a tumor suppressor and an important mediator of epithelial–immune crosstalk in HNSCC, linking epithelial differentiation‐associated states to antitumor immunity through the CREB1/CXCL16/CXCR6 axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesSquamous Cell Carcinoma of Head and NeckChemokine CXCL16Cyclic AMP Response Element-Binding ProteinHead and Neck NeoplasmsHumansSignal TransductionAnimalsPrognosisReceptors, CXCR6Gene Expression Regulation, NeoplasticCell Line, TumorLymphocytes, Tumor-InfiltratingDisease ProgressionMiceCell ProliferationCell Movement

Stichwörter der Autor:innen

CXCL16–CXCR6 axisHNSCCYPEL3epithelial–immune crosstalktumor immune microenvironment

Substanzen

Chemokine CXCL16Cyclic AMP Response Element-Binding ProteinReceptors, CXCR6CXCR6 protein, human

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai, China.
  • Shandong Provincial Key Laboratory of Neuroimmune Interaction and Regulation, Yantai, China.
  • Shandong Provincial Clinical Research Center for Otorhinolaryngologic Diseases, Yantai, China.
  • Yantai Key Laboratory of Otorhinolaryngologic Diseases, Yantai, China.
  • School of Basic Medicine, Qingdao University, Yantai, China.
  • Department of Breast Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai, China.

ORCID-Profile: Gang Chen, Xicheng Song

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • China Postdoctoral Science Foundation
  • Special Clinical Research Grant of the Wu Jieping Medical Foundation

Zitieren

APA

Li, Y., Li, Y., Sun, C., Lu, C., Chen, G., Zhou, T., Zhang, B., & Song, X. (2026). Epithelial YPEL3 Modulates CD8 + T‐Cell Infiltration and Tumor Progression Through CREB1–CXCL16 Signaling in HNSCC. Cancer Science, 117(8), 2132-2151. https://doi.org/10.1111/cas.70409

Vancouver

Li Y, Li Y, Sun C, Lu C, Chen G, Zhou T, et al. Epithelial YPEL3 Modulates CD8 + T‐Cell Infiltration and Tumor Progression Through CREB1–CXCL16 Signaling in HNSCC. Cancer Science. 2026;117(8):2132-2151. doi:10.1111/cas.70409

BibTeX
@article{Li2026,
  author = {Li, Yalun and Li, Yumei and Sun, Caiyu and Lu, Congxian and Chen, Gang and Zhou, Tianshu and Zhang, Bei and Song, Xicheng},
  title = {Epithelial YPEL3 Modulates CD8 + T‐Cell Infiltration and Tumor Progression Through CREB1–CXCL16 Signaling in HNSCC},
  journal = {Cancer Science},
  year = {2026},
  volume = {117},
  number = {8},
  pages = {2132--2151},
  doi = {10.1111/cas.70409}
}
Kostenlos starten →